Literature DB >> 33864281

Efficacy of dupilumab for controlling severe atopic dermatitis with dominant-negative CARD11 variant.

E Charvet1, E Bourrat1,2,3, G Hickman1, J Donadieu4, C Bellanné-Chantelot5,6, M Jachiet1, J-D Bouaziz1,2,3,4, M Bagot1,2,3,4, C Cassius1,2,3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33864281     DOI： 10.1111/ced.14686

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  1 in total

1.  Hyper-IgE and Carcinoma in CADINS Disease.

Authors:  Leonora Pietzsch; Julia Körholz; Felix Boschann; Mildred Sergon; Batsukh Dorjbal; Debra Yee; Vanessa Gilly; Eva Kämmerer; Diana Paul; Clemens Kastl; Martin W Laass; Reinhard Berner; Eva Maria Jacobsen; Joachim Roesler; Daniela Aust; Min A Lee-Kirsch; Andrew L Snow; Catharina Schuetz
Journal:  Front Immunol       Date:  2022-05-16       Impact factor: 8.786
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.